TREA

90867247 - ADAPT

Follow

Information

  • Trademark
  • 90867247
  • Serial Number
    90867247
  • Filing Date
    August 05, 2021
    3 years ago
  • Transaction Date
    February 14, 2024
    a year ago
  • Status Date
    May 09, 2023
    a year ago
  • Location Date
    May 09, 2023
    a year ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 119 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    LOVELACE, JAMES B
  • Attorney Docket Number
    203596002000
    Attorney Name
    Jennifer Lee Taylor
    Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ADAPT
Case File Statements
  • GS0051: Pharmaceutical products, preparations, and substances for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; biological products, preparations, and substances in the nature of medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; immunotherapies being medical preparations for the prevention and treatment of cancer, infectious diseases, allergies, mental illnesses, chemotherapy side effects, radiation side effects, transplantation side effects, and viral, metabolic, cardiovascular, vascular, pulmonary, blood, dermatologic, fibrotic, autoimmune, inflammatory, neurodegenerative, neuromuscular, dietary deficiency, hereditary, endocrine, eye, ear, and voice related diseases and disorders; vaccines; pharmaceuticals in the nature of biotechnology platform technology, namely, viral and vaccine vectors for delivery and insertion of function-altering genetic material into human and animal patients, plants, and crops, for visualization of specific cell types, for inducing humoral and cell-mediated responses, for targeting and killing cancer cells, for removing pathological functions, for controlling biological pests, and for boosting crop yields
Case File Event Statements
  • 5/9/2023 - a year ago
    15 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/9/2023 - a year ago
    14 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 5/9/2023 - a year ago
    13 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 10/25/2022 - 2 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/25/2022 - 2 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 10/25/2022 - 2 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 9/23/2022 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/22/2022 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/22/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/22/2022 - 3 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/22/2022 - 3 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/22/2022 - 3 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/16/2022 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/30/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/9/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP